Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 24-month follow-up

BACKGROUND: Dimethyl fumarate and fingolimod are oral disease-modifying therapies approved to treat relapsing multiple sclerosis. Prior observational studies and our previous 12-month investigation showed comparable clinical efficacy. OBJECTIVE: The purpose of this study was to assess real-world eff...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Mult Scler J Exp Transl Clin
Main Authors: Hersh, Carrie M, Love, Thomas E, Bandyopadhyay, Anasua, Cohn, Samuel, Hara-Cleaver, Claire, Bermel, Robert A, Fox, Robert J, Cohen, Jeffrey A, Ontaneda, Daniel
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2017
Teme:
Original Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5574489/
https://ncbi.nlm.nih.gov/pubmed/28890796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217317715485
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki